Minerva Surgical Long Term Debt

The latest long-term debt for UTRS is $31M as of September 2023. That compares with $39M in the prior-year period — down 20.4% year over year. Investors often review this figure alongside Minerva Surgical's historical trend and sector peers before judging valuation or financial health.

Over the past year, UTRS's long-term debt moved from $39M to $31M — a 20.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Minerva Surgical's operating scale or balance-sheet position.

A long-term debt figure of $31M for UTRS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting UTRS's long-term debt ($31M), review year-over-year change from $39M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Minerva Surgical's long-term debt against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.